Meta-Analysis on Garlic and Cholesterol Management
Findings from the "most comprehensive" meta-analysis on garlic and blood lipids.
Because conflicting data exists, Australian researchers have finished what they say is the most comprehensive meta-analysis of studies on garlic (Allium sativum) and cholesterol management.
Researchers from the University of Adelaide gathered data from 39 garlic trials on subjects with high cholesterol. Studies measured for changes in total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. When garlic preparations were consumed for more than two months daily, subjects experienced significant reductions in total cholesterol (17 +/-6 mg/dL) and LDL cholesterol (9 +/-6 mg/dL). Such improvements, according to the researchers, can be associated with a 38% reduced risk of serious cardiovascular events at 50 years of age.
Tolerability of garlic products was high across all studies, suggesting that garlic can be a safe alternative to conventional cholesterol-lowering medications for those with slightly high cholesterol.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.
